16 filings
8-K
TCDAQ
Tricida, Inc.
18 Dec 19
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
12:00am
8-K
TCDAQ
Tricida, Inc.
14 Nov 19
Tricida Announces Third Quarter 2019 Financial Results
4:34pm
8-K
TCDAQ
Tricida, Inc.
15 Oct 19
Regulation FD Disclosure
8:03am
8-K
TCDAQ
Tricida, Inc.
10 Oct 19
Entry into a Material Definitive Agreement
4:25pm
8-K
TCDAQ
Tricida, Inc.
4 Sep 19
Tricida Announces Submission of New Drug Application for Veverimer for the Treatment of Metabolic Acidosis in Patients with Chronic Kidney Disease
9:27am
8-K
h8wm8
19 Aug 19
Entry into a Material Definitive Agreement
4:19pm
8-K
9hg339xkasvu gt243
8 Aug 19
Tricida Announces Second Quarter 2019 Financial Results
4:08pm
8-K
8zkrh63o ru
25 Jun 19
Tricida Announces Publication of Positive Long-Term Phase 3 Clinical Trial Results of Veverimer (TRC101) in The Lancet
8:35am
8-K
i702 5bmayd
31 May 19
Submission of Matters to a Vote of Security Holders
4:39pm
8-K
cens6suox8c94j
8 May 19
Tricida Announces First Quarter 2019 Financial Results
4:08pm
8-K
d0q7klwv8vv4ezb4
28 Mar 19
Tricida Announces Positive Results from Long-Term Clinical Trial
7:29am
8-K
3b3px1
28 Mar 19
Entry into a Material Definitive Agreement
7:27am
8-K
9idas2 qnyfn
28 Mar 19
Tricida Announces Fourth Quarter and Full-Year 2018 Financial Results
7:25am
8-K
hm8pv
22 Feb 19
Departure of Directors or Certain Officers
12:00am
8-K
yyxqa pzs3
7 Jan 19
Regulation FD Disclosure
8:52am
8-K
27q3i
3 Jan 19
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
12:00am
- Prev
- 1
- Next